Myriad Genetics | MYGN - Stock


Myriad Genetics reported $31.6M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Agilent USD 1.03B 11M Sep/2025
Becton, Dickinson and Co. USD 3.89B 55M Sep/2025
Bio-Rad Laboratories USD 783.2M 15.6M Sep/2025
Bruker USD 1.2B 21.7M Sep/2025
Danaher USD 2.49B 185M Dec/2025
Exact Sciences USD 164.78M 6.72M Sep/2025
Hologic USD 688.5M 9.1M Dec/2025
Illumina USD 564M 26M Dec/2025
J&J USD 14.15B 734M Sep/2025
Mettler Toledo International USD 401.81M 13.73M Sep/2025
Myriad Genetics USD 31.6M 2.9M Sep/2025
Quest Diagnostics USD 186M 1000K Sep/2025
Quidel USD 613.8M 35.1M Sep/2025
Repligen USD 160.32M 4.46M Sep/2025
Revvity USD 379.92M 8.55M Sep/2025
Standard Biotools USD 25.42M 1.25M Sep/2025
Thermo Fisher Scientific USD 5.43B 320M Dec/2025
Veracyte USD 20.33M 4.69M Sep/2025
Waters USD 572.94M 32.19M Sep/2025